NET PROFIT (x1000 SEK)
EMPLOYEES
Scanpharm A/S
Closing information (x1000 SEK)
Closing information | 2021/12 | 2020/12 | 2019/12 |
Turnover | 0 | 0 | 0 |
Earnings before taxes | -14,832 | -23,071 | -5,556 |
Total assets | 39,760 | 43,478 | 49,114 |
Current assets | 20,071 | 22,610 | 25,276 |
Current liabilities | 32,271 | 33,908 | 34,607 |
Equity capital | 2,063 | 2,581 | 8,226 |
- share capital | 4,126 | 4,048 | 4,190 |
Employees (average) | 75 | 75 | 35 |
Financial ratios
Fiscal year | 2021/12 | 2020/12 | 2019/12 |
Solvency | 5.2% | 5.9% | 16.7% |
Turnover per employee | 0 | 0 | 0 |
Profit as a percentage of turnover | |||
Return on assets (ROA) | |||
Current ratio | 62.2% | 66.7% | 73.0% |
Return on equity (ROE) | -719.0% | -893.9% | -67.5% |
Change turnover | 0 | 0 | 0 |
Change turnover % | |||
Chg. No. of employees | 0 | 40 | 0 |
Chg. No. of employees % | 0% | 114% | 0% |
Total value of public sale
Fiscal year | 2021/12 | 2020/12 | 2019/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.